Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

African Americans have higher average Lp(a) levels and are more likely to have heart disease than non-Hispanic whites, but there is not enough information on Lp(a) and cardiovascular disease risk in this population.

News | Stroke

A New Mechanism Encouraging the Brain to Self-repair After an Ischemic Stroke

August 14, 2023 — Patients often experience functional decline after an ischemic stroke, especially due to the brain’s ...

August 14, 2023

The FDA has announced that Datascope/Maquet/Getinge is recalling the Cardiosave Hybrid and Rescue Intra-aortic Balloon Pumps (IABPs) because they may shutdown unexpectedly due to electrical failures in the Power Management Board and/or Solenoid Board (Power Source Path).

News | Intra-Aortic Balloon Pumps (IABP)

Datascope/Maquet/Getinge Recalls Cardiosave Hybrid and Rescue Intra-aortic Balloon Pumps (IABPs) for Unexpected Shutdowns

August 14, 2023 — The FDA has announced that Datascope/Maquet/Getinge is recalling the Cardiosave Hybrid and Rescue ...

August 14, 2023

It is the position of SCAI that ABIM diplomates who successfully pass their exams and report procedural volumes in a timely fashion should be indisputably recognized as “certified” for the respective time frame

News | Cardiovascular Business

SCAI Position on ABIM Revocation of Certification for Not Participating in MOC

August 10, 2023 — It is the position of SCAI that ABIM diplomates who successfully pass their exams and report ...

August 10, 2023

News | Cardiovascular Clinical Studies

Heart Study’s Goal: Better Understand and Serve the Underrepresented

August 10, 2023 — Cardiovascular disease is the number one killer of all Americans. Yet, African Americans are 30% more ...

August 10, 2023

News | Artificial Intelligence

AI Breakthrough Award Presented to Cleerly CCTA Digital Care Platform

August 10, 2023 — Cleerly, an artificial intelligence (AI) digital healthcare company, recently announced it was named ...

August 10, 2023

As medical advancements continue to push the boundaries of what is possible in the field of structural heart interventions, the importance of enterprise imaging has become increasingly evident.

Blog | Enterprise Imaging

BLOG: The Power of Enterprise Imaging in Structural Heart Procedures

As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...

August 10, 2023

Although at greater risk, a new study found that patients of African ancestry with dilated cardiomyopathy (DCM) were less likely to have clinically actionable variants in DCM genes than those of European ancestry.

News | Cardiovascular Clinical Studies

Study Reveals Significant Difference in Cardiomyopathy Genes Between Black and White Patients

August 8, 2023 — Although at greater risk, a new study found that patients of African ancestry with dilated ...

August 08, 2023

The Society of Cardiovascular Computed Tomography (SCCT) presented two winners of the 17th Annual Canon Young Investigator Awards (YIA)

News | SCCT

SCCT names Canon Young Investigator Awards winners

August 8, 2023 — The Society of Cardiovascular Computed Tomography (SCCT) presented two winners of the 17th Annual Canon ...

August 08, 2023

The Society of Cardiovascular Computed Tomography (SCCT) presented three winners of the Best Abstract Awards

News | SCCT

SCCT Awards Best Abstracts of 18th Annual Scientific Meeting

August 7, 2023 — The Society of Cardiovascular Computed Tomography (SCCT) presented three winners of the Best Abstract ...

August 07, 2023

The medication, known as a “polypill,” includes three active ingredients (acetylsalicylic acid, ramipril, and atorvastatin)

News | Nuclear Imaging

World Health Organization Includes the Cardiovascular Polypill in its list of Essential Medicines after a Groundbreaking Study Led by the President of Mount Sinai Heart

August 3, 2023 — The cardiovascular polypill, developed by the Spanish National Centre for Cardiovascular Research (CNIC ...

August 03, 2023

Merit’s WAVE study is a prospective, randomized, controlled, multicenter study

News | Cardiovascular Clinical Studies

Merit Medical’s WRAPSODY Arteriovenous Access Efficacy (WAVE) Pivotal Study Completes Enrollment

August 3, 2023 — Merit Medical Systems, a leading global manufacturer and marketer of healthcare technology, today ...

August 03, 2023

India clinical trial commences with first 30 cases

News | Heart Valve Technology

First Patients Outside of U.S. Treated with TRIA Polymer Surgical Mitral Heart Valve

August 2, 2023 — Foldax , Inc., a leader in the development of innovative, polymer heart valves, today announced that ...

August 02, 2023

Dr. Scortichini is recognized across the Finger Lakes and Greater Rochester region as one of the most respected and accomplished cardiologists

News | Cardiovascular Business

Dr. Doria A. Scortichini MD, FACC Joins Auburn Heart Institute

August 2, 2023 — Dr. Doria Scortichini, MD FACC joins the growing Auburn Heart Institute that is affiliated with Aubur ...

August 02, 2023

Eleven Hackensack Meridian hospitals have been awarded the American Heart Association / American Stroke Association Get With The Guidelines Stroke Gold Plus Award.

News | Cardiovascular Business

Eleven Hackensack Meridian Health Hospitals Nationally Recognized For Stroke Care By American Heart Association and American Stroke Association Get With The Guidelines Stroke Awards

August 1, 2023 — Hackensack Meridian Health hospitals are being recognized for their readiness to respond and care for s ...

August 01, 2023

LX2020 preclinical studies demonstrated proof-of-concept with treatment restoring desmosomal integrity, reducing arrhythmias, and extending survival in a clinically relevant murine model

News | Pharmaceuticals

LEXEO Therapeutics Announces FDA Clearance of IND for LX2020, an AAV-based Gene Therapy Candidate for PKP2 Arrhythmogenic Cardiomyopathy

August 1, 2023 —LEXEO Therapeutics, a clinical-stage gene therapy company advancing adeno-associated virus (AAV)-based ...

August 01, 2023